RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin ™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as ...

Avita’s RECELL platform harnesses the regenerative properties of a small piece of the patient’s own skin to create what the company calls Spray-On Skin Cells. These different cell types ...

AVITA Medical receives FDA approval of RECELL GO mini, a new addition to the RECELL Spray-On Skin™ technology platform. VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: ...

RECELL harnesses the regenerative properties of a patient's own skin to create Spray-On Skin ™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as ...

RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology ...

The US Food and Drug Administration (FDA) has approved a premarket approval (PMA) supplement for Avita Medical’s RECELL GO mini, a line extension of the existing RECELL GO system. RECELL GO mini ...

Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of ...